126 related articles for article (PubMed ID: 16406695)
1. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
[TBL] [Abstract][Full Text] [Related]
2. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
3. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy.
Fröscher W; Schier KR; Hoffmann M; Meyer A; May TW; Rambeck B; Rösche J
Epileptic Disord; 2005 Sep; 7(3):237-48. PubMed ID: 16162434
[TBL] [Abstract][Full Text] [Related]
4. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
[TBL] [Abstract][Full Text] [Related]
5. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
Ferrari AR; Guerrini R; Gatti G; Alessandrì MG; Bonanni P; Perucca E
Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
[TBL] [Abstract][Full Text] [Related]
8. Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.
Doose DR; Brodie MJ; Wilson EA; Chadwick D; Oxbury J; Berry DJ; Schwabe S; Bialer M
Epilepsia; 2003 Jul; 44(7):917-22. PubMed ID: 12823574
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in patients with learning disability and refractory epilepsy.
Kelly K; Stephen LJ; Sills GJ; Brodie MJ
Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing serum topiramate concentrations in routine therapeutic drug monitoring in Korean adult patients with epilepsy.
Huh HJ; Joo EY; Hong SB; Ahn JH; Seo DW; Lee SY
Ther Drug Monit; 2013 Apr; 35(2):177-82. PubMed ID: 23503443
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
13. Age and antiepileptic drugs influence topiramate plasma levels in children.
Dahlin MG; Ohman IK
Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in refractory epilepsy: a prospective observational study.
Stephen LJ; Sills GJ; Brodie MJ
Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
[TBL] [Abstract][Full Text] [Related]
15. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
16. Topiramate serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and monitoring implications.
Adín J; Gómez MC; Blanco Y; Herranz JL; Armijo JA
Ther Drug Monit; 2004 Jun; 26(3):251-7. PubMed ID: 15167623
[TBL] [Abstract][Full Text] [Related]
17. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
19. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients.
Thijs J; Verhelst H; Van Coster R
Acta Neurol Belg; 2001 Sep; 101(3):171-6. PubMed ID: 11817266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
